Unjha Formulations Ltd
BSE:531762
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Unjha Formulations Ltd
Operating Income
Unjha Formulations Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
U
|
Unjha Formulations Ltd
BSE:531762
|
Operating Income
4.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
Operating Income
₹28B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
7%
|
|
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
Operating Income
₹134.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
C
|
Colgate-Palmolive (India) Ltd
NSE:COLPAL
|
Operating Income
₹17.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Procter & Gamble Hygiene and Health Care Ltd
NSE:PGHH
|
Operating Income
₹11.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
|
Dabur India Ltd
NSE:DABUR
|
Operating Income
₹19.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Unjha Formulations Ltd
Glance View
Unjha Formulations Ltd. engages in the manufacturing and export of Ayurvedic products. The company is headquartered in Sidhpur, Gujarat. The firm is focused on the development of export markets for Fibron SF Powder, Albendazole Bolus and Fibermate (isabgol based formulations). The firm's principal products and services include POWDER, TABLETS, Veterinary medicinal formulation not for Human and FIBRON. The firm's Anchor Sat-Isabgol (Isabgo Husk Formulation in Elaichi Flavor) is available in approximately 50 grams (gms), 100 gms, 200 gms and 400gms. The firm's Fibron and Fibron SF (Sugar Free) are available in approximately 100 gms and 300 gms. The company also manufactures various kinds of Small Volume Ayurvedic Isabgol (Psyllium) powder.
See Also
What is Unjha Formulations Ltd's Operating Income?
Operating Income
4.2m
Based on the financial report for Mar 31, 2025, Unjha Formulations Ltd's Operating Income amounts to 4.2m .
What is Unjha Formulations Ltd's Operating Income growth rate?
Operating Income CAGR 1Y
-16%
Over the last year, the Operating Income growth was -16%.
